Animal models of fibromyalgia

被引:91
作者
DeSantana, Josimari M. [1 ,2 ,3 ]
da Cruz, Kamilla M. L. [3 ]
Sluka, Kathleen A. [4 ]
机构
[1] Univ Fed Sergipe, Dept Phys Therapy, BR-49060100 Aracaju, Sergipe, Brazil
[2] Univ Fed Sergipe, Grad Program Hlth Sci, BR-49060100 Aracaju, Sergipe, Brazil
[3] Univ Fed Sergipe, Grad Program Physiol Sci, BR-49060100 Aracaju, Sergipe, Brazil
[4] Univ Iowa, Pain Res Program, Dept Phys Therapy & Rehabil Sci, Iowa City, IA 52241 USA
关键词
CHRONIC MUSCLE PAIN; STRESS-INDUCED HYPERALGESIA; REPEATED INTRAMUSCULAR INJECTION; RESERPINE-INDUCED MYALGIA; NMDA RECEPTOR ACTIVATION; EXPERIMENTAL MOUSE MODEL; PROTEIN-KINASE-C; MECHANICAL HYPERALGESIA; SUBSTANCE-P; CUTANEOUS HYPERALGESIA;
D O I
10.1186/ar4402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Animal models of disease states are valuable tools for developing new treatments and investigating underlying mechanisms. They should mimic the symptoms and pathology of the disease and importantly be predictive of effective treatments. Fibromyalgia is characterized by chronic widespread pain with associated co-morbid symptoms that include fatigue, depression, anxiety and sleep dysfunction. In this review, we present different animal models that mimic the signs and symptoms of fibromyalgia. These models are induced by a wide variety of methods that include repeated muscle insults, depletion of biogenic amines, and stress. All potential models produce widespread and long-lasting hyperalgesia without overt peripheral tissue damage and thus mimic the clinical presentation of fibromyalgia. We describe the methods for induction of the model, pathophysiological mechanisms for each model, and treatment profiles.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] ADVANCES IN THE MANAGEMENT OF FIBROMYALGIA
    Arnold, Lesley M.
    CNS SPECTRUMS, 2009, 14 (10) : 12 - 16
  • [42] Fibromyalgia syndrome: An overview
    KrsnichShriwise, S
    PHYSICAL THERAPY, 1997, 77 (01): : 68 - 75
  • [43] Substance P and fibromyalgia
    Russell, IJ
    JOURNAL OF MUSCULOSKELETAL PAIN, 1998, 6 (03): : 29 - 35
  • [44] Pharmacological relapse prevention in alcohol dependence: From animal models to clinical trials
    Boening, JAL
    Lesch, OM
    Spanagel, R
    Wolffgramm, J
    Narita, M
    Sinclair, D
    Mason, BJ
    Wiesbeck, GA
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 25 (05): : 127S - 131S
  • [45] Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
    Gilhar, Amos
    Schrum, Adam G.
    Etzioni, Amos
    Waldmann, Herman
    Paus, Ralf
    AUTOIMMUNITY REVIEWS, 2016, 15 (07) : 726 - 735
  • [46] Animal Welfare Aspects in Planning and Conducting Experiments on Rodent Models of Subarachnoid Hemorrhage
    Becker, Katrin
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2023, 43 (08) : 3965 - 3981
  • [47] Benefits and limitations of animal models in partial bladder outlet obstruction for translational research
    Kitta, Takeya
    Kanno, Yukiko
    Chiba, Hiroki
    Higuchi, Madoka
    Ouchi, Mifuka
    Togo, Mio
    Moriya, Kimihiko
    Shinohara, Nobuo
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (01) : 36 - 44
  • [48] Cellular and molecular mechanisms of coronary artery spasm - Lessons from animal models
    Shimokawa, H
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 2000, 64 (01): : 1 - 12
  • [49] Animal models of migraine and experimental techniques used to examine trigeminal sensory processing
    Harriott, Andrea M.
    Strother, Lauren C.
    Vila-Pueyo, Marta
    Holland, Philip R.
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (01)
  • [50] Neoteric pharmacotherapeutic targets in fibromyalgia
    Chopra, Kanwaljit
    Kuhad, Anurag
    Arora, Vipin
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (11) : 1267 - 1281